These observations prompted us to speculate that Bax/Smac axis may be one of key determinants of chemosensitivity in cisplatin-resistant ovarian cancer cells, and that NOXA-induced alterations in the Bax/Smac Axis may enhance sensitivity of ovarian cancer cells to cisplatin. This evidence concerns the gene PMAIP1 and ovarian carcinoma.